Investors
CSE: ADPT
Information for shareholders and prospective investors.
Key information
Corporate snapshot.
| Exchange | Canadian Securities Exchange (CSE) |
|---|---|
| Symbol | ADPT |
| Headquarters | Vancouver, British Columbia |
| Strategy | Proprietary peptides, small molecules and delivery technologies |
| Existing business | Nutrition and supplements |
Adaptogenics continues to operate its existing nutrition and supplement business and is evaluating potential GLP 1 companion product opportunities.
Early stage strategy. Outcomes are uncertain and no program is guaranteed to advance. Adaptogenics has not announced any owned or licensed peptide asset in this strategy.
Investment highlights
Why Adaptogenics.
- 01Experienced leadership
A medicinal chemist with deep peptide experience and a healthcare dealmaker with public company experience.
- 02Large therapeutic markets
Initial interests span metabolic health, muscle and physical function, mitochondrial biology and inflammation resolution.
- 03Several routes to value
Asset acquisition, focused discovery, molecular optimization and differentiated delivery.
- 04Clear disclosure
We publish only verified, publicly issued information and state plainly what we do and do not own.
News releases
Latest from the company.
Official news releases will be posted here as they are issued.